New eye drug combo aims to tackle Diabetes-Related vision loss

NCT ID NCT07425522

First seen Feb 24, 2026 · Last updated Jun 18, 2026 · Updated 16 times

Summary

This early-stage study tests a new medicine called RO7823653, given as an eye injection, for people with diabetic macular edema (DME) — a condition that causes blurry vision due to diabetes. The study will check if the drug is safe and tolerable when used alone or together with another approved drug (faricimab). About 93 adults with DME will take part, and researchers will monitor side effects, vision changes, and drug levels in the eye and blood.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETIC MACULAR EDEMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Associated Retina Consultants - Peoria - DocTrials - PPDS

    RECRUITING

    Peoria, Arizona, 85381-3690, United States

  • Austin Clinical Research, LLC

    RECRUITING

    Austin, Texas, 78750-2298, United States

  • Erie Retina Research, LLC - 300 State St

    RECRUITING

    Erie, Pennsylvania, 16507-1429, United States

  • Piedmont Eye Center

    RECRUITING

    Lynchburg, Virginia, 24502-4271, United States

  • Retina Consultants of Texas Westover Hills Retina Center

    RECRUITING

    San Antonio, Texas, 78251, United States

  • Retina Research Institute of Texas

    RECRUITING

    Abilene, Texas, 79606-1224, United States

  • Retina Vitreous Associates of Florida

    RECRUITING

    St. Petersburg, Florida, 33711-1141, United States

  • Retina-Vitreous Associates Medical Group

    RECRUITING

    Beverly Hills, California, 90211-1838, United States

Conditions

The condition(s) this trial relates to.

diabetic macular edema

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.